Cash-Flow King Hold: Is $5,000 a Forever Bet for Markets?
Vertex Pharmaceuticals is being pitched as a durable cash-flow king for patient investors. This piece analyzes the ca...
Learn why index funds are a popular choice for retirement, offering broad market exposure, low fees, and straightforward, scalable strategy.
24,587 articlesVertex Pharmaceuticals is being pitched as a durable cash-flow king for patient investors. This piece analyzes the ca...
Sen. JD Vance faulted the Trump administration's handling of Epstein-related documents, calling out missteps in commu...
A leading tech investor envisions a future where AI-enabled labor trims traditional work yet expands access to essent...
A second Dan Sullivan surfaces on Alaska’s August ballot for the U.S. Senate, sparking legal questions and concerns a...
Moonshot AI unveils the Kimi K3 model, sparking a swift repricing in AI bets and sending chipmakers and tech names in...
A motley coalition of middle powers cannot shore up a fragile rules-based order, economist eswar prasad warns. The do...
A bipartisan effort seeks to temporarily lift the capital gains exclusion for seniors selling primary residences to u...
A new memoir and interview place Lloyd Blankfein at the center of a renewed debate over risk, accountability, and how...
Stocks slid Friday as investors weighed whether AI-driven growth can sustain lofty valuations. Analysts warn this cou...
OpenAI CEO Sam Altman acknowledges AI is shifting the traditional labor-capital balance, highlighting job fears as au...
At this year’s Fortune COO Summit, a simple question exposed a quiet truth: many COOs hesitate to voice CEO ambitions...
A career setback in 1998 launched Jamie Dimon's rise to the helm of JPMorgan Chase. This piece draws lessons for pers...